Treatment for Sjögren's Syndrome: Options, Medications & Outlook
Evidence-based Sjögren's Syndrome treatment: first-line medications, monitoring targets, escalation criteria, and long-term clinical outlook.
Updated March 27, 2026
Treatment for Sjögren's Syndrome focuses on achieving remission or low disease activity, preventing structural damage, and maintaining functional capacity. Sjögren's syndrome is an autoimmune disease primarily affecting the salivary and lacrimal glands, causing dry eyes (xerophthalmia) and dry mouth (xerostomia). It can be primary or secondary to other autoimmune diseases like RA or lupus.
Clinical Context
The primary approach involves NSAIDs, DMARDs (methotrexate first-line in RA), biologic agents (anti-TNF, anti-IL-6, JAK inhibitors), or hydroxychloroquine for SLE. Monitoring typically includes disease activity scores (DAS28, BASDAI), FBC and LFTs for DMARD toxicity, and joint imaging. Treatment intensity is tailored to disease severity, patient comorbidities, and response. Guideline-directed therapy reduces the risk of complications, hospitalisation, and disease progression.
Clinical Pathway
Sjögren's Syndrome — Full Condition GuideCondition HubSjögren's Syndrome — Treatment PathwaysTreatmentSjögren's Syndrome — Prognosis & OutlookPrognosisSjögren's Syndrome — Differential DiagnosisDifferentialSjögren's Syndrome vs. Systemic Lupus Erythematosus (SLE) — Comparisonvs.Frequently Asked Questions
Treatment for Sjögren's Syndrome: Options, Medications & Outlook?+
Treatment for Sjögren's Syndrome focuses on achieving remission or low disease activity, preventing structural damage, and maintaining functional capacity. Sjögren's syndrome is an autoimmune disease primarily affecting the salivary and lacrimal glands, causing dry eyes (xerophthalmia) and dry mouth (xerostomia). It can be primary or secondary to other autoimmune diseases like RA or lupus.
What is the first-line treatment for Sjögren's Syndrome?+
First-line treatment typically involves NSAIDs, DMARDs (methotrexate first-line in RA), biologic agents (anti-TNF, anti-IL-6, JAK inhibitors), or hydroxychloroquine for SLE. The specific agent and dose are tailored to your presentation and clinical profile.
How long does treatment for Sjögren's Syndrome last?+
Some conditions require short-term treatment (acute infections, self-limiting disorders). Many chronic conditions require indefinite treatment to maintain disease control and prevent relapse.
What happens if Sjögren's Syndrome is not treated?+
Untreated Sjögren's Syndrome can progress, increasing the risk of complications and organ damage. Early treatment generally leads to better outcomes and reduced long-term burden.
Our AI Symptom Checker analyzes your symptoms and suggests possible conditions based on clinical guidelines.
Start Free Analysis →